Rebecca Byam, Chief Financial Officer at HCW Biologics Inc. (HCWB), bought 90,300 shares at $2.50 ($229K) on 2022-08-24, disclosed to the SEC on 2022-08-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 50,000 | $125K | 54.5% |
| 2 | $2.59 | 40,300 | $104K | 45.5% |
| Total | $2.54 avg | 90,300 | $229K | 100% |
| Filing → |
| HCWB | BUY | 2023-09-15 | $11K | — | Filing → |
| HCWB | BUY | 2023-09-13 | $21K | — | Filing → |
| HCWB | BUY | 2023-09-08 | $20K | — | Filing → |